Discovery and systematic assessment of early biomarkers that predict progression to severe COVID-19 disease
Description
CONCLUSIONS: Using these biomarkers, patients at high risk of developing a severe or critical disease may be selected for treatment with specialized therapeutic options such as neutralizing antibodies or antivirals. Early therapy through early
